| Schedule of Computation of Basic and Diluted Net (Loss) Profit per Share |
The following table sets forth the computation of the Company’s basic and diluted net (loss) income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(11,464 |
) |
|
$ |
(16,129 |
) |
|
$ |
(24,836 |
) |
|
$ |
(39,176 |
) |
Less: Net loss attributable to redeemable noncontrolling interests |
|
|
(5,501 |
) |
|
|
(12,063 |
) |
|
|
(13,400 |
) |
|
|
(29,621 |
) |
Less: Net income attributable to noncontrolling interests |
|
|
1,413 |
|
|
|
698 |
|
|
|
2,443 |
|
|
|
658 |
|
Add: Series A Preferred Dividends |
|
|
(1,291 |
) |
|
|
(1,032 |
) |
|
|
(2,720 |
) |
|
|
(2,039 |
) |
Add: Series B Preferred Dividends |
|
|
— |
|
|
|
(1,305 |
) |
|
|
— |
|
|
|
(2,297 |
) |
Net loss attributable to common stockholders |
|
$ |
(8,667 |
) |
|
$ |
(7,101 |
) |
|
$ |
(16,599 |
) |
|
$ |
(14,549 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Class A Common Stock outstanding |
|
|
46,055,296 |
|
|
|
20,199,586 |
|
|
|
42,231,163 |
|
|
|
19,470,304 |
|
Weighted Average Class A Common Stock issuable under Series A Penny Warrants |
|
|
1,542,578 |
|
|
|
1,304,742 |
|
|
|
1,525,823 |
|
|
|
1,293,803 |
|
Weighted Average Class A Common Stock issuable under Series B Penny Warrants |
|
|
6,268,100 |
|
|
|
6,268,100 |
|
|
|
6,268,100 |
|
|
|
5,707,614 |
|
Weighted Average Shares Outstanding - basic and diluted |
|
|
53,865,974 |
|
|
|
27,772,428 |
|
|
|
50,025,086 |
|
|
|
26,471,721 |
|
Basic and Diluted Earnings (Loss) Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.16 |
) |
|
$ |
(0.26 |
) |
|
$ |
(0.33 |
) |
|
$ |
(0.55 |
) |
Diluted |
|
$ |
(0.16 |
) |
|
$ |
(0.26 |
) |
|
$ |
(0.33 |
) |
|
$ |
(0.55 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following table summarizes potentially dilutive outstanding securities for the three and six months ended June 30, 2026 and 2025 which were excluded from the calculation of diluted EPS, because their effect would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended |
|
|
For the six months ended |
|
|
For the three and six months ended |
|
|
|
June 30, 2026 |
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
Public warrants |
|
|
2,519,869 |
|
|
|
2,519,869 |
|
|
|
2,519,869 |
|
Private Placement Warrants |
|
|
4,333,333 |
|
|
|
4,333,333 |
|
|
|
4,333,333 |
|
Series A Penny Warrants |
|
|
1,542,578 |
|
|
|
1,525,823 |
|
|
|
1,304,742 |
|
Class B Common Stock |
|
|
49,930,000 |
|
|
|
52,637,182 |
|
|
|
59,930,000 |
|
Total anti-dilutive features |
|
|
58,325,780 |
|
|
|
61,016,207 |
|
|
|
68,087,944 |
|
|